Natalizumab Intravenous and Verapamil Immediate-Release Tablets
Determining the interaction of Natalizumab Intravenous and Verapamil Immediate-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: natalizumab
Brand name: Tysabri
Synonyms: Natalizumab
Generic Name: verapamil
Brand name: Calan, Isoptin SR, Verelan, Isoptin, Calan SR, Isoptin IV, Covera-HS, Verelan PM
Synonyms: Verapamil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Natalizumab Intravenous-Verapamil Injection
- Natalizumab Intravenous-Verapamil Intravenous
- Natalizumab Intravenous-Verapamil Long-Acting Capsules
- Natalizumab Intravenous-Verapamil Long-Acting Tablets
- Natalizumab Intravenous-Verapamil oral/injection
- Natalizumab Intravenous-Verapamil Sustained-Release Capsules
- Verapamil Immediate-Release Tablets-Natalvirt 90 DHA
- Verapamil Immediate-Release Tablets-Natalvirt CA
- Verapamil Immediate-Release Tablets-Natazia
- Verapamil Immediate-Release Tablets-Nateglinide
- Verapamil Immediate-Release Tablets-Natelle Complete
- Verapamil Immediate-Release Tablets-Natelle One